Dexcom
Dexcom Inc is an American medical device company that designs, develops, and commercializes continuous glucose monitoring systems for people living with diabetes. The company's main products consist of wearable sensors and transmitters that measure glucose levels in real time, transmitting data wirelessly to mobile applications or dedicated receivers. Its primary revenue drivers are the recurring sales of disposable sensors, transmitters, and related software platforms used by individuals with type 1 and type 2 diabetes. The end market primarily comprises the global healthcare sector, with distribution flowing through pharmacies, medical equipment suppliers, and direct-to-consumer channels reimbursed by commercial and government insurers. Dexcom holds a major global market position in continuous glucose monitoring technology alongside competitors in the diabetes care industry. The company is headquartered in San Diego, California, and its common stock is publicly listed on the Nasdaq Stock Market under the ticker symbol DXCM.
60 of the funds FundTelligence covers report a position in Dexcom.
- Legal name
- Dexcom Inc.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 60
- Exposure themes
- Diabetes Technology, Glucose monitoring, Glucose Monitoring, Monitoring and disease management, Obesity & Metabolic Health, Women's Health
Funds holding Dexcom
- C WorldWide Healthcare Select — C WorldWide · 4.4 % (largest positions only, October 2026)
- GS Global Future Health Care Equity Portfolio — Goldman Sachs · 3.77 % (largest positions only, September 2026)
- UBS Mid Caps USA Equity Fund — UBS · 2.7 % (largest positions only, September 2026)
- DNB Health Care — DNB · 2.47 % (full portfolio disclosed, September 2026)
- Lannebo Global Growth — Lannebo · 2.35 % (full portfolio disclosed, June 2026)
- Baillie Gifford Worldwide Positive Change Fund — Baillie Gifford · 2.29 % (full portfolio disclosed, September 2026)
- HealthInvest Sustainable Healthcare — HealthInvest · 2.0 % (partially disclosed portfolio, September 2026)
- Schroder ISF Healthcare Innovation — Schroders · 1.73 % (full portfolio disclosed, June 2026)
Showing the 8 largest of 60 funds holding it.